Saito Fumiyo, Yokota Hirofumi, Sudo Yoshihisa, Yakabe Yoshikuni, Takeyama Haruko, Matsunaga Tadashi
Chemicals Evaluation and Research Institute, Japan, 1600 Shimo-Takano, Sugito, Kitakatsushika, Saitama 345-0043, Japan.
Toxicol In Vitro. 2006 Dec;20(8):1343-53. doi: 10.1016/j.tiv.2006.05.007. Epub 2006 Jun 3.
RNA interference (RNAi) has become a popular tool for downregulating in many species including mammalian cells. Therefore, suppression of target genes in mammalian cultured cells using RNAi may represent an ideal alternative to knockout studies for understanding the molecular mechanisms of chemical toxicity. Here, we assessed the potential of RNAi mediated gene knockdown in HeLa and HepG2 cells to cytotoxicity studies. Tumor necrosis factor receptor I (TNFRI) was chosen as a target gene because its signaling has been implicated in xenobiotic-induced toxicity. We optimized the design and performance of a vector-based RNAi experiment and then investigated viability of both HeLa and HepG2 cells exposed to TNFalpha. In addition, we examined gene expression profile of TNFRI knockdown HeLa cells after TNFalpha treatment, and then protein expression levels for several apoptosis-related genes of the cells. In both HeLa and HepG2 cells, TNFalpha exposure resulted in significantly reduced susceptibility of the knockdown cells to the cytotoxicity as compared with those of mock-transfected cells. Furthermore, the gene expression profiling and western blotting revealed that several genes including apoptosis and/or NF-kappaB pathway were downregulated in the knockdown HeLa cells. These results suggest that downregulation of the TNFRI gene in both HeLa and HepG2 cells by RNAi participates in resistance to TNFalpha-induced cytotoxicity. Therefore, this study raises the possibility that RNAi-based gene silencing in mammalian cells may be a valuable tool for elucidating the relationships between phenotypic changes and target gene functions in response to xenobiotic-induced cytotoxicity. Further exposure study using xenobiotics needs to be done to validate the potential utility of RNAi technology.
RNA干扰(RNAi)已成为在包括哺乳动物细胞在内的许多物种中下调基因表达的常用工具。因此,利用RNAi抑制哺乳动物培养细胞中的靶基因,可能是一种理想的替代基因敲除研究的方法,用于理解化学毒性的分子机制。在此,我们评估了RNAi介导的基因敲低在HeLa和HepG2细胞中用于细胞毒性研究的潜力。选择肿瘤坏死因子受体I(TNFRI)作为靶基因,因为其信号传导与异生物素诱导的毒性有关。我们优化了基于载体的RNAi实验的设计和操作,然后研究了暴露于TNFα的HeLa和HepG2细胞的活力。此外,我们检测了TNFα处理后TNFRI敲低的HeLa细胞的基因表达谱,以及这些细胞中几个凋亡相关基因的蛋白质表达水平。在HeLa和HepG2细胞中,与mock转染细胞相比,暴露于TNFα导致敲低细胞对细胞毒性的敏感性显著降低。此外,基因表达谱分析和蛋白质印迹显示,在敲低的HeLa细胞中,包括凋亡和/或NF-κB途径在内的几个基因表达下调。这些结果表明,RNAi介导的HeLa和HepG2细胞中TNFRI基因的下调参与了对TNFα诱导的细胞毒性的抗性。因此,本研究提出了一种可能性,即哺乳动物细胞中基于RNAi的基因沉默可能是阐明表型变化与靶基因功能之间关系以应对异生物素诱导的细胞毒性的有价值工具。需要使用异生物素进行进一步的暴露研究,以验证RNAi技术的潜在效用。